Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$48.00 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY PDF Report Brief Display this book on your site! Related Titles Radiation in Medicine:A Need for Regulatory Reform Assuring a Future U.S.-Based Nuclear and Radiochemistry Expertise Other Related Titles Advancing Nuclear Medicine Through Innovation (2007) Nuclear and Radiation Studies Board (NRSB) Board on Health Sciences Policy (HSP) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix C Commercially Available Radiopharmaceuticals." Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press, 2007. Please select a format: Page 151   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix C Commercially Available Radiopharmaceuticals Radiopharmaceutical Trade Name Primary Uses Carbon-14 Urea Pytest Detection of H Pylori Cobalt-57 cyanocobalamin Rubratope Schilling test Chromium-51 sodium chromate Chromitope (Bracco) Mallinckrodt Cr-51 Labeling red blood cells (RBC) Fluorine-18-FDG   Positron emission tomography (PET) imaging Gallium-67 Neoscan (GE) DuPont Ga-67 Mallinckrodt Ga-67 Soft-tissue tumor and inflammatory process imaging Indium-111 chloride Indiclor (Nycomed) Mallinckrodt In-111Cl Labeling monoclonal antibodies and peptides (OncoScint & Octreoscan) Indium-111 pentetate (DTPA) Indium DTPA In-111 Imaging of cerebrospinal fluid kinetics Indium-111 oxyquinoline (oxine) Indium-111 oxine Labeling leukocytes and platelets Indium-111 Capromab pendetide ProstaScint Monoclonal antibody for imaging prostate cancer Page 151 Front Matter (R1-R14) Summary (1-9) 1 Introduction (10-16) 2 Nuclear Medicine (17-42) 3 Nuclear Medicine Imaging in Diagnosis and Treatment (43-58) 4 Targeted Radionuclide Therapy (59-74) 5 Availability of Radionuclides for Nuclear Medicine Research (75-88) 6 Radiotracer and Radiopharmaceutical Chemistry (89-103) 7 Instrumentation and Computational Sciences (104-117) 8 Education and Training of Nuclear Medicine Personnel (118-130) References (131-140) Appendix A Information-Gathering Sessions (141-145) Appendix B Glossary and Acronyms (146-150) Appendix C Commercially Available Radiopharmaceuticals (151-154) Appendix D Biographical Sketches Of Committee Members (155-159)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 151
Advancing Nuclear Medicine through Innovation Appendix C Commercially Available Radiopharmaceuticals Radiopharmaceutical Trade Name Primary Uses Carbon-14 Urea Pytest Detection of H Pylori Cobalt-57 cyanocobalamin Rubratope Schilling test Chromium-51 sodium chromate Chromitope (Bracco) Mallinckrodt Cr-51 Labeling red blood cells (RBC) Fluorine-18-FDG   Positron emission tomography (PET) imaging Gallium-67 Neoscan (GE) DuPont Ga-67 Mallinckrodt Ga-67 Soft-tissue tumor and inflammatory process imaging Indium-111 chloride Indiclor (Nycomed) Mallinckrodt In-111Cl Labeling monoclonal antibodies and peptides (OncoScint & Octreoscan) Indium-111 pentetate (DTPA) Indium DTPA In-111 Imaging of cerebrospinal fluid kinetics Indium-111 oxyquinoline (oxine) Indium-111 oxine Labeling leukocytes and platelets Indium-111 Capromab pendetide ProstaScint Monoclonal antibody for imaging prostate cancer

OCR for page 152
Advancing Nuclear Medicine through Innovation Radiopharmaceutical Trade Name Primary Uses Indium-111 pentetreotide Octreoscan Imaging neuroendocrine tumors I-123 sodium iodide Mallinckrodt Amersham Thyroid imaging and uptake I-125 iothalamate Glofil Measurement of glomerular filtration I-125 human serum albumin (RISA) Isojex Plasma volume determinations I-131sodium iodide Iodotope (Bracco) CIS - I-131 Mallinckrodt I-131Soln Mallinckrodt I-131 Therapy Caps Mallinckrodt I-131 Diagnostic Caps Thyroid uptake, imaging, and therapy Tositumomab & Iodine I-131 Tositumomab Bexxar Treatment of non-Hodgkin’s lymphoma I-131 iodomethylnorcholesterol (NP-59) (University of Michigan) Adrenal imaging I-131 metaiodobenzylguanidine (MIBG) I-131 MIBG Imaging pheochromocytomas and neuroblastomas P-32 chromic phosphate Phosphocol P32 Therapy for intracavitary malignancies P-32 sodium phosphate   Therapy for polycythemia vera Rubidium-82 (from Sr-82/Rb-82 generator) Cardio-Gen-82 PET imaging Samarium-153 Lexidronam (Sm-153 EDTMP) Quadramet Palliative treatment of bone pain of skeletal metastases Strontium-89 Metastron Palliative treatment of bone pain of skeletal metastases

OCR for page 153
Advancing Nuclear Medicine through Innovation Radiopharmaceutical Trade Name Primary Uses Tc-99m pertechnetate Generators DuPont Mallinckrodt DTE Mallinckrodt FM Amersham Imaging thyroid, salivary glands, ectopic gastric mucosa, parathyroid glands, dacryocystography, cystography Tc-99m Apcitide AcuTect Peptide imaging of deep vein thrombosis Tc-99m bicisate (ECD) Neurolite Cerebral perfusion imaging Tc-99m disofenin (DISIDA) Hepatolite-CIS Hepatobiliary imaging Tc-99m exametazine (HMPAO) Ceretec Cerebral perfusion imaging Tc-99m Gluceptate Draximage Mallinckrodt Renal imaging Tc-99m human serum albumin (HSA)   Imaging cardiac chambers Tc-99m macroaggregated albumin (MAA) Pulmolite - CIS Macrotec (Bracco) Technescan MAA (Mallinckrodt) Draximage Amersham MAA Pulmonary perfusion Tc-99m Mebrofenin Choletec Hepatobiliary imaging Tc-99m Medronate (MDP) Bracco Osteolite - CIS Draximage Mallinckrodt Amersham Bone imaging Tc-99m Mertiatide Technescan MAG3 Renal imaging Tc-99m Oxidronate (HDP) Mallinckrodt HDP Bone imaging Tc-99m Pentetate (DTPA) Techneplex (Bracco) CIS-AN DTPA CIS-DTPA Draximage DTPA Mallinckrodt DTPA Nycomed DTPA Renal imaging and function studies; Radioaerosol ventilation imaging

OCR for page 154
Advancing Nuclear Medicine through Innovation Radiopharmaceutical Trade Name Primary Uses Tc-99m Pyrophosphate (PYP) Phosphotec (Bracco) Pyrolite-CIS Pyro-CIS Technescan PYP Amersham PYP Avid infarct imaging; in vivo RBC labeling Tc-99m red blood cells Ultratag Imaging gastrointestinal (GI) bleeds, cardiac chambers Tc-99m Sestamibi Cardiolite Miraluma Myocardial perfusion imaging Breast tumor imaging Tc-99m Succimer (DMSA) Amersham DMSA Renal imaging Tc-99m Sulfur Colloid (SC) CIS-Sulfur Colloid Nycomed - SC Imaging liver/spleen, gastric emptying, GI bleeds Tc-99m Tetrofosmin Myoview Myocardial perfusion imaging Thallium-201 DuPont Mallinckrodt Amersham Myocardial perfusion imaging; Parathyroid and tumor imaging Y-90 Ibitumomab Tiuxetan Zevalin non-Hodgkin’s lymphoma Xenon-133 DuPont Xenon Mallinckrodt Xenon Amersham Xenon Pulmonary ventilation imaging Interventional Agents Trade Name Use in nuclear medicine ACD solution (anticoagulant acid Acitrate dextrose) ACD Solution Modified Anticoagulant used in blood labeling Adenosine Adenoscan Pharmacologic stress Ascorbic acid Ascorbic acid RBC labeling and HDP preparation I.V. Dipyridamole I.V. Persantine Pharmacologic stress Sincalide Kinevac Gallbladder ejection fraction studies SOURCE: University of Arkansas for Medical Sciences (http://nuclearpharmacy.uams.edu/resources/PackageInserts.asp).

Representative terms from entire chapter:

name primary